Pharmaceutical compositions comprising tri-agonists of the GLP-1, GIP, and amylin receptors

TW202631182APending Publication Date: 2026-08-01NOVO NORDISK AS
View PDF 0 Cites 0 Cited by

Patent Information

Authority / Receiving Office
TW · TW
Patent Type
Applications
Current Assignee / Owner
Filing Date
2024-11-29
Publication Date
2026-08-01

Smart Images

  • Figure TWG2TA001071934_001
    Figure TWG2TA001071934_001
  • Figure TWG2TA001071934_002
    Figure TWG2TA001071934_002
  • Figure TWG2TA001071934_003
    Figure TWG2TA001071934_003
Patent Text Reader

Abstract

The present invention relates to a GLP-1- / GIP- / amylin-receptor tri-agonist. This GLP-1- / GIP- / amylin-receptor tri-agonist may have improved pharmacokinetic properties and may be suitable for once weekly administration. The invention also relates to pharmaceutical compositions comprising such a GLP-1- / GIP- / amylin-receptor tri-agonist. The tri-agonist and pharmaceutical compositions comprising it may be used as a medicament for the treatment of subjects with overweight, obesity and associated co-morbidity.
Need to check novelty before this filing date? Find Prior Art